Loading…
Telomir Pharmaceuticals, Inc. is projected to rise to $1.34 by 2027, a +4% move from its current price of $1.29. TELO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.25 | $1.29 | $1.33 | -0.02% |
| May 30 | $1.24 | $1.29 | $1.34 | -0.04% |
| May 31 | $1.23 | $1.29 | $1.35 | -0.06% |
| Jun 1 | $1.22 | $1.29 | $1.36 | -0.08% |
| Jun 2 | $1.21 | $1.29 | $1.37 | -0.10% |
| Jun 3 | $1.20 | $1.29 | $1.38 | -0.13% |
| Jun 4 | $1.20 | $1.29 | $1.39 | -0.15% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.20 | $1.29 | $1.39 | -0.15% |
| Week 2 | $1.16 | $1.29 | $1.43 | -0.29% |
| Week 3 | $1.13 | $1.28 | $1.46 | -0.44% |
| Week 4 | $1.11 | $1.28 | $1.48 | -0.59% |
| Week 5 | $1.09 | $1.28 | $1.51 | -0.73% |
| Week 6 | $1.07 | $1.28 | $1.53 | -0.88% |
| Week 7 | $1.05 | $1.28 | $1.55 | -1.02% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Telomir Pharmaceuticals, Inc. is a preclinical-stage biotechnology company focused on developing small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases.
The company is building Telomir-1, an oral small molecule metal ion regulator intended to protect against a range of age-related conditions, including Wilson's disease, Type 2 diabetes, AMD, oncology, epigenetic regulation, Alzheimer's disease, and Progeria.
Telomir was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. It was incorporated in 2021 and is headquartered in Miami, Florida.
Telomir Pharmaceuticals trades under the TELO symbol. The current price is $1.29, and the company has a market capitalization of $88.72M with a rank of 4298.
The price outlook, based on the provided year-by-year forecast, suggests a bullish trajectory over the long term. Forecas ts show average prices rising across years—from $1.29 in 2026 to $4.90 by 2050—with the potential for higher maximums (up to $9.32 in 2050). ROI climbs from 0% in 2026 to 280% by 2050, reflecting a shift from neutral to bullish sentiment in later years.
The forecasted path occurs alongside notable volatility, as indicated by an annualized volatility of 60%.
A major floor 20.2% below — a decisive break under it would weaken the trend.
The nearest floor, 7.8% below — buyers have tended to step in here.
The nearest ceiling, 14.7% above — a clean break opens room to run.
A major ceiling 24.8% above — clearing it would confirm fresh momentum.
Key TELO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TELO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.30 | Sell | $1.29 | Buy |
| MA 10 | $1.26 | Buy | $1.28 | Buy |
| MA 20 | $1.30 | Sell | $1.30 | Sell |
| MA 50 | $1.32 | Sell | $1.31 | Sell |
| MA 100 | $1.30 | Sell | $1.33 | Sell |
| MA 200 | $1.36 | Sell | $1.58 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.31 | Neutral |
| Stoch RSI (14) | 85.76 | Sell |
| CCI (20) | -19.43 | Neutral |
| Williams %R (14) | -23.08 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -0.77 | Sell |
| Bollinger %B (20,2) | 0.45 | Neutral |
| Stochastic %K (14) | 76.92 | Neutral |
| TRIX (15) | -0.20 | Sell |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 51.73 | Neutral |
| Momentum (10) | 0.03 | Buy |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 1.31 | Sell |
| ADX (14) | 10.57 | Neutral |
| ATR (14) | 0.03 | Info |
In the near term, the technical picture is bearish despite a neutral RSI of 50. The price is trading around key moving averages, with the SMA50 at $1.32 and the SMA200 at $1.37, suggesting resistance above the current level.
Support is identified at $1.19 and resistance at $1.48, with a 30-day trading range from $1.06 to $1.57. These levels imply limited downside risk near the support zone but a clear hurdle near the resistance, guiding potential short-term price action.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.08 | $1.29 | $1.62 | 0% | Neutral | |
| $1.06 | $1.34 | $1.79 | +4% | Neutral | |
| $1.25 | $1.62 | $2.24 | +25% | Bullish | |
| $1.29 | $1.72 | $2.45 | +33% | Bullish | |
| $1.35 | $1.83 | $2.68 | +42% | Bullish | |
| $1.31 | $1.80 | $2.69 | +40% | Bullish | |
| $1.21 | $1.71 | $2.59 | +32% | Bullish | |
| $1.32 | $1.89 | $2.92 | +46% | Bullish | |
| $1.53 | $2.22 | $3.49 | +72% | Bullish | |
| $1.66 | $2.44 | $3.89 | +89% | Bullish | |
| $1.91 | $3.00 | $5.09 | +133% | Bullish | |
| $2.77 | $4.90 | $9.10 | +280% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.08 | $1.29 | $1.50 | +0.00% |
| June 2026 | $1.06 | $1.24 | $1.50 | -3.52% |
| July 2026 | $1.07 | $1.27 | $1.54 | +1.69% |
| August 2026 | $1.05 | $1.26 | $1.55 | -0.75% |
| September 2026 | $1.02 | $1.22 | $1.52 | -2.62% |
| October 2026 | $1.04 | $1.25 | $1.57 | +2.41% |
| November 2026 | $1.07 | $1.30 | $1.64 | +3.64% |
| December 2026 | $1.05 | $1.28 | $1.62 | -1.46% |
Click any year to see its month-by-month TELO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, TELO could reach as high as $1.62, with a base case around $1.29 and support toward $1.08 — roughly 0% from $1.29. A consolidation phase looks the most probable path here.
Expect TELO to range from $1.06 to $1.79 through 2027. The $1.34 average target implies a +4% move from current prices. That is up +4% on the projected 2026 average. Price action looks broadly range-bound.
The TELO price prediction for 2028 points to an average of $1.62 (low $1.25, high $2.24) — a potential gain of +25% on today's $1.29. Buyers look set to stay in control over this stretch.
In 2029, TELO is projected to trade between $1.29 and $2.45, averaging $1.72 — a potential gain of +33% from today's $1.29. That is up +6% on the projected 2028 average. Momentum favours further upside here.
Telomir Pharmaceuticals, Inc.'s 2030 outlook centres on $1.83, within a $1.35 to $2.68 range. That is up +7% on the projected 2029 average. That marks a +42% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, TELO could reach as high as $2.69, with a base case around $1.80 and support toward $1.31 — roughly +40% from $1.29. Momentum favours further upside here.
Expect TELO to range from $1.21 to $2.59 through 2032. The $1.71 average target implies a +32% move from current prices. That is -5% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
The TELO price prediction for 2033 points to an average of $1.89 (low $1.32, high $2.92) — a potential gain of +46% on today's $1.29. Momentum favours further upside here.
In 2034, TELO is projected to trade between $1.53 and $3.49, averaging $2.22 — a potential gain of +72% from today's $1.29. That is up +17% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Telomir Pharmaceuticals, Inc.'s 2035 outlook centres on $2.44, within a $1.66 to $3.89 range. That is up +10% on the projected 2034 average. That marks a +89% change versus current levels. Momentum favours further upside here.
By 2040, TELO could reach as high as $5.09, with a base case around $3.00 and support toward $1.91 — roughly +133% from $1.29. Buyers look set to stay in control over this stretch.
Expect TELO to range from $2.77 to $9.10 through 2050. The $4.90 average target implies a +280% move from current prices. That is up +63% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in TELO today (≈ 775.193798 TELO) could be worth
$3,799.84
+$2,799.84 (+280%) by 2050 · US Dollar
Based on the average projected TELO price of $4.9 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TELOwould be worth at today's price.
$1,000 invested in TELO on May 27, 2025 (≈ 476.190498 TELO) would be worth
$614.29
-$385.71 (-38.6%) today · 0.61× · US Dollar
Based on a TELO entry price of $2.1 vs. today's $1.29.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.31 | $984.73 | -1.5% |
| 1 month ago | $1.42 | $908.45 | -9.2% |
| 3 months ago | $1.31 | $984.73 | -1.5% |
| 6 months ago | $1.34 | $962.69 | -3.7% |
| 1 year ago | $2.1 | $614.29 | -38.6% |
| All time (2.3y) ago | $5 | $258 | -74.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TELO forecast.
Our base-case forecast reaches $2.60 around 2040.
Implied market cap at $2.60: $178.81M
The multi-year forecast shows a bullish trajectory after a neutral start, with 2026-avg at $1.29 and gradually rising through the late 2020s and beyond. The sequence features 2027 avg $1.34, 2028 $1.64, 2029 $1.73, 2030 $1.85, 2031 $1.81, 2032 $1.69, 2033 $1.91, 2034 $2.25, and 2035 $2.45, followed by stronger gains in 2040 at $3.04 and 2050 at $4.90. ROI progresses from 0% in 2026 to 3.9% in 2027, then 27% in 2028, 33.9% in 2029, 43.8% in 2030, 40.6% in 2031, 31.1% in 2032, 48.1% in 2033, 74.5% in 2034, 90.2% in 2035, 135.5% in 2040, and 280% in 2050, with sentiment labeled bullish in later years.
This implies a long-run bullish tilt with rising average prices and sizable potential upside, albeit within a high-volatility context (60% annualized volatility). As always, these are estimates, not guarantees, and actual results may vary.
Tap a question to reveal the answer.
2030 forecast: min $1.35, avg $1.85, max $2.75; ROI 43.8%; sentiment BULLISH.
The forecast shows positive long-term momentum, with averages rising across years and several years posting positive ROI (e.g., 2027 3.9%, 2028 27%, 2029 33.9%, 2030 43.8%, 2040 135.5%, 2050 280%). However, near-term signals include neutral or bearish indicators and high volatility (60%), so these are estimates, not guarantees.
Yes. The forecast lists 2033 max at $3.00, 2034 max at $3.60, 2035 max at $3.98, 2040 max at $5.26, and 2050 max at $9.32, indicating potential for $3 or more in several future years.
Current price is $1.29. Market capitalization is $88.72M. The asset ranks 4298 by market cap.
The average forecast price rises from $1.29 in 2026 to $4.90 in 2050, with a maximum of $9.32 in 2050 and an eventual ROI of 280%. Forecast sentiment shifts from NEUTRAL in 2026–2027 to BULLISH in later years, set against 60% volatility.
Telomir Pharmaceuticals, Inc. Community Discussion
0Share your Telomir Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.